Overview

A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants

Status:
Completed
Trial end date:
2019-10-11
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to achieve mass balance recovery of [14C]-radiolabel in urine and feces and to identify and quantify the main elimination pathways of E2027.
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Inc.